Group 1 - The company's stock price closed at 14.58 yuan on August 25, with a decrease of 0.02 yuan, representing a decline of 0.14% [1] - The trading volume on that day was 116,300 hands, with a transaction amount of 169 million yuan [1] - The company operates in the chemical pharmaceutical industry, focusing on the research, production, and sales of chemical raw materials and pharmaceutical intermediates [1] Group 2 - On August 25, the company announced that its isosorbide mononitrate tablets received a drug registration certificate from the National Medical Products Administration [1] - This medication is indicated for the long-term treatment of coronary heart disease and the prevention of angina pectoris [1] Group 3 - On August 25, the net outflow of main funds was 16.39 million yuan, accounting for 0.44% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow of main funds reached 38.2 million yuan, representing 1.02% of the circulating market value [1]
润都股份股价微跌0.14% 单硝酸异山梨酯片获批注册